As GLOW has no trial-established dose, the derived range is 1.4-4.2 mg per injection: Low Dose: 1.4 mg (1 mg GHK-Cu + 200 mcg BPC-157 + 200 mcg TB-4) Standard Dose: 2.8 mg (2 mg GHK-Cu + 400 mcg BPC-157 + 400 mcg TB-4) Elevated Dose: 4.2 mg (3 mg GHK-Cu + 600 mcg BPC-157 + 600 mcg TB-4) What is the GLOW dose per day
In other words, in addition to inhibiting the expression of p-STAT3, GHK-Cu likely targets other pathways that inhibit the expression of inflammatory factors
10.1016/j.yjmcc.2013.12.015 J Mol Cell Cardiol
Amount Per Serving
[DOI] [PubMed] [Google Scholar] Ferr S, Casad V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives
[DOI] [PubMed] [Google Scholar] Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M (2007) Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine